New task order award for maintenance, development and production of schistosomiasis parasites, reagents and assays
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
American Foundation For Biological Research UEI PT82EFQ7AL94
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,826,579
Award facts
- Contract value 100% obligated
- $4,826,578.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$370,134 | |
| Terminate for Convenience | $0 | |
| Exercise an Option | $1,850,671 | |
| Exercise an Option | $1,729,597 | |
| Original award | $1,616,445 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order to American Foundation For Biological Research, doing business as Biomedical Research Institute (BRI), for maintenance, development, and production of schistosomiasis parasites, reagents, and assays. This task order, valued at $4.83M with a completion date of January 31, 2026, was awarded on February 1, 2023, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle. The contract utilizes cost-no-fee pricing and carries no set-aside designation. Performance will be conducted in Potomac, Maryland. This award represents a partial termination for option period 2 under NIAID's cost efficiency initiative.
BRI is a non-profit parasitology research specialist headquartered in Rockville, Maryland, with established expertise in providing live parasites and related biological materials to support federal infectious disease research. The organization's focus on schistosomiasis research has made it a critical partner for NIAID, with previous contract awards involving specialized tasks such as harvesting and delivering parasite eggs and cercariae for vaccine research and disease studies. This delivery order continues BRI's specialized support for NIAID's research initiatives targeting parasitic infectious diseases.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to American Foundation For Biological Research by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 1, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $4,826,579 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under HHSN272201700014I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award